Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.
Metrics to compare | LIFEA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIFEAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | 24.0x | −0.5x | |
PEG Ratio | 0.01 | 0.35 | 0.00 | |
Price/Book | −13.3x | 5.2x | 2.6x | |
Price / LTM Sales | 44.0x | 4.9x | 3.3x | |
Upside (Analyst Target) | - | 53.3% | 48.1% | |
Fair Value Upside | Unlock | 10.7% | 7.7% | Unlock |